The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

I.A. Demidova

FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN", Moskva;
FGBU "Moskovskiĭ NII pediatrii i detskoĭ khirurgii Minzdrava Rossii", Moskva;
Moskovskiĭ gorodskoĭ psikhologo-pedagogicheskiĭ universitet, Moskva

E.O. Tsepenshchikova

Moscow City Cancer Hospital Sixty-Two, Moscow Department of Healthcare, Moscow, Russia

M.B. Gikalo

Moscow City Cancer Hospital Sixty-Two, Moscow Department of Healthcare, Moscow, Russia

Use of the new 2013 ASCO/CAP guidelines to study HERS status by fluorescence in situ hybridization in patients with breast cancer

Authors:

I.A. Demidova, E.O. Tsepenshchikova, M.B. Gikalo

More about the authors

Views: 529

Downloaded: 16


To cite this article:

Demidova IA, Tsepenshchikova EO, Gikalo MB. Use of the new 2013 ASCO/CAP guidelines to study HERS status by fluorescence in situ hybridization in patients with breast cancer. Russian Journal of Archive of Pathology. 2015;77(5):43‑51. (In Russ.)
https://doi.org/10.17116/patol201577543-51

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.